Trial intelligence / Profile preview

Intra-erythrocyte dexamethasone for cystic fibrosis

2007-001782-15Phase 2Active

Sponsor
Istituto Giannina Gaslini
Start
Jul 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of dexamethasone in cystic fibrosis (CF), sponsored by Istituto Giannina Gaslini. Primary endpoint: Change in FEV1 over prior 18 months. Started Jul 2007; status: active.

02

Drugs

dexamethasone
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on 2007-001782-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001782-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call